The correlation between the cytotoxic T lymphocyte associated antigen 4 gene polymorphism and autoimmune thyroid disease

Journal of Xi'an Jiaotong University (Medical Sciences)

Volumn 24, Issue 2, 2003, Pages 170-173

  Zhou, Wenxu ^a   Shi, Bingyin ^a   Wang, Huifang ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038030596     PISSN: 16718259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Knudsen N , Jorgensen T , Rasmussen S , et al . The prevalence of thyroid disfunction in a population with borderline iodine deficiency [J]. Clin Endocrinol, 1999,51:361-367.
2. Brix H, Hegedus L. Genetic predisposition versus environmental factors in autoimmune thyroid disease [A] In: Peter F, Wiersinga W, Hostale KU, eds. The thyroid and environment [M]. Germany: Schattauer, 2000. 105-119.
3. Kouki T, Gardine CA, Yanagawa T, et al. Relation of three polymorphisms of the CTLA4 gene in patients with Graves' disease [J]. Endocrinol Invest, 2002,25(3):208-213.
4. Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, et al. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease [J]. Clin Immunol, 2001,101(3):361-365.
5. Donner H, Rau H, Walfish PG, et al. CTLA alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus [J]. Clin Endocrinol Metab, 1997,82(1):143-146.
6. Deichmann K, Heinzmann A, Bruggenolte E, et al. An Mse I RFLP in the human CTLA4 promotor [J]. Biochem Biophys Res Commun, 1996,225(3):817-818.
7. Heward J, Gough SC. Genetic susceptibility to the development of autoimmune disease [J]. Clin Sci(Lond), 1997,93(6):479-491.
8. Braun J, Donner H, Siegmund T, et al. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis [J]. Tissue Antigens, 1998,51(5):563-566.
9. Park YJ, Chung HK, Park DJ, et al. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans [J]. Thyroid, 2000,10(6):453-459.
10. Heward JM, Allahabadia A, Carr-Smith J, et al. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies [J]. Clin Endocrinol (Oxf), 1998,49(3):331-334.
11. Heward JM, Allahabadia A, Armitage M, et al. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33 [J]. Clin Endocrinol Metab, 1999,84(7):2398-2401.
12. Dariavach P, Mattei MG, Golstein P, et al. Human Ig superfamily CTLA-4 gene: chromosomal localization and identify of protein sequence between murine and human an CTLA4 cytoplasm is domains [J]. Eur Immunol, 1988,18(10):1901-1905.
13. Takara M, Komiya I, Kinjo Y, et al. Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease [J]. Diabetes Care, 2000,23(7):975-978.
14. Ligers A, Teleshoya N, Masterman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms [J]. Genes Immun, 2001,2(3):145-152.
15. Yanagawa T, Hidaka Y, Guimaraes V, et al. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population [J]. Clin Endocrinol Metab, 1995,80(1):41-45.
16. Donner H, Braun J, Seidl C, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease [J]. Clin Endocrinol Metab, 1997,82(12):4130-4132.